Bdr Lifesciences Private Ltd, based in India, is a pharmaceutical company.
One of their notable products is ENZALUTAMIDE, with a corresponding US DMF Number 40067.
Remarkably, this DMF maintains an Active status since its submission on September 23, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 24, 2024, and payment made on September 11, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II